Cargando…

Trimethylamine N‐oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction

AIM: Accumulating evidence has demonstrated that intestinal microbiota‐dependent trimethylamine N‐oxide (TMAO) is involved in the pathogenesis of various cardiovascular diseases. The present study was designed to investigate the prognostic value of TMAO in patients with chronic heart failure (CHF) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiang, Jin, Mengchao, Liu, Lei, Yu, Zongliang, Lu, Xiang, Zhang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083407/ https://www.ncbi.nlm.nih.gov/pubmed/31960610 http://dx.doi.org/10.1002/ehf2.12552

Ejemplares similares

Association between trimethylamine N‐oxide and prognosis of patients with acute myocardial infarction and heart failure
por: Li, Nan, et al.
Publicado: (2022)

Serum corin is associated with the risk of chronic heart failure
por: Yu, Zongliang, et al.
Publicado: (2017)

Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Ethnic differences in association of outcomes with trimethylamine N‐oxide in acute heart failure patients
por: Yazaki, Yoshiyuki, et al.
Publicado: (2020)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

The Impact of Trimethylamine N-Oxide and Coronary Microcirculatory Dysfunction on Outcomes following ST-Elevation Myocardial Infarction
por: Aldujeli, Ali, et al.
Publicado: (2023)

Trimethylamine N‐oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction
por: Kinugasa, Yoshiharu, et al.
Publicado: (2021)

Trimethylamine N-Oxide in Heart Failure: A Meta-Analysis of Prognostic Value
por: Li, Xingxing, et al.
Publicado: (2022)

Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
por: Almesned, Mohammad A., et al.
Publicado: (2021)

Trimethylamine-N-Oxide: The Link Between Loop Diuretics and Cardiovascular Outcomes?
por: Adel, Fadi W., et al.
Publicado: (2021)

It's a “Gut Feeling”: Association of Microbiota, Trimethylamine N‐Oxide and Cardiovascular Outcomes
por: Kolluru, Gopi K., et al.
Publicado: (2020)

Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction
por: Bin Waleed, Khalid, et al.
Publicado: (2020)

Association of trimethylamine N-Oxide with cardiovascular and all-cause mortality in hemodialysis patients
por: Zhang, Pan, et al.
Publicado: (2020)

Trimethyllysine, a trimethylamine N-oxide precursor, predicts the presence, severity, and prognosis of heart failure
por: Zong, Xiao, et al.
Publicado: (2022)

Heart failure and trimethylamine N‐oxide: time to transform a ‘gut feeling’ in a fact?
por: Crisci, Giulia, et al.
Publicado: (2022)

Trimethylamine-N-oxide is an important target for heart and brain diseases
por: Ding, Shusi, et al.
Publicado: (2022)

Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial
por: Gencer, Baris, et al.
Publicado: (2020)

Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction
por: Guo, Fei, et al.
Publicado: (2020)

Sex-specific differences in trimethylamine N-oxide (TMAO) concentrations before and after cardiac rehabilitation in acute myocardial infarction patients
por: Baranyi, Andreas, et al.
Publicado: (2022)

Association between the Changes in Trimethylamine N-Oxide-Related Metabolites and Prognosis of Patients with Acute Myocardial Infarction: A Prospective Study
por: Li, Nan, et al.
Publicado: (2022)

Serological short-chain fatty acid and trimethylamine N-oxide microbial metabolite imbalances in young adults with acute myocardial infarction
por: Avendaño-Ortiz, José, et al.
Publicado: (2023)

Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism
por: Yoshida, Yohko, et al.
Publicado: (2022)

Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI
por: Matsuzawa, Yasushi, et al.
Publicado: (2019)

Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease
por: Roncal, Carmen, et al.
Publicado: (2019)

Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
por: Constantino-Jonapa, Luis A., et al.
Publicado: (2023)

Comparative Efficacy of Medical Treatments for Chronic Heart Failure: A Network Meta-Analysis
por: Xiang, Boyang, et al.
Publicado: (2022)

Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease
por: Zhang, Honghong, et al.
Publicado: (2022)

Trimethylamine N-Oxide: The Good, the Bad and the Unknown
por: Velasquez, Manuel T., et al.
Publicado: (2016)

Trimethylamine N-oxide in atrial fibrillation progression
por: Büttner, Petra, et al.
Publicado: (2020)

Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021)

Influence of Trimethylamine N-Oxide on Platelet Activation
por: Emonds, Julian Josef, et al.
Publicado: (2022)

The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison
por: Evans, Marie, et al.
Publicado: (2023)

Addition of Plasma Myeloperoxidase and Trimethylamine N-Oxide to the GRACE Score Improves Prediction of Near-Term Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction
por: Tan, Yu, et al.
Publicado: (2021)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022)

Oxidation of trimethylamine to trimethylamine N-oxide facilitates high hydrostatic pressure tolerance in a generalist bacterial lineage
por: Qin, Qi-Long, et al.
Publicado: (2021)

Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease
por: Bean, Lamuel D., et al.
Publicado: (2022)

Neighborhood Environment Associates with Trimethylamine-N-Oxide (TMAO) as a Cardiovascular Risk Marker
por: Farmer, Nicole, et al.
Publicado: (2021)

Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db/db mice
por: Kuka, Janis, et al.
Publicado: (2020)

Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study
por: Lever, Michael, et al.
Publicado: (2014)

Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies
por: Qi, Jiaqian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_83u4q1qv72104kpclb0ur8uf47